FDA inspection

MicroBiopharm Japan Co., Ltd.: FDA inspection ending Mar 16, 2018

FDA inspection 1045597 · Voluntary Action Indicated (VAI) · Iwata

Key facts

Inspection ID 1045597
Firm MicroBiopharm Japan Co., Ltd.
FEI number 3003992082
Address 1808, Nakaizumi
City Iwata
Country Japan
Fiscal year 2018
Inspection end date Mar 16, 2018
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections